When treating locally advanced nasopharyngeal carcinoma with chemoradiation, do you offer adjuvant, induction, or no additional chemotherapy beyond standard chemoradiation?
How do you decide? Do the results of recently published phase III data in the Lancet Oncology (Sun et al, Sept 2016) influence your decision making?
Answer from: Medical Oncologist at Academic Institution
I try to enroll any pateint on the current NRG protocol. I will, however, consider adjuvant chemotherapy in some cases, i.e. those with bulkly disease upon imaging after definitive chemoRT, suggesting that the patient may not have had a CR to definitive therapy (who are not study candidates). Sin...
Comments
Medical Oncologist at Kaiser Permanente Does the results of the NEJM induction with cis/ge...
Radiation Oncologist at Memorial Sloan Kettering Cancer Center No. The NEJM trial just informs us that if we were...
Does the results of the NEJM induction with cis/ge...
No. The NEJM trial just informs us that if we were...